SAM
EGRX

Shell Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Shell Asset Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,809
Closed -$152K – 1286
2023
Q2 		$152K Sell
7,809
-43
-0.5% -$1.02K 0.01% 1009
2023
Q1 		$223K Sell
7,852
-28
-0.4% -$831 0.01% 895
2022
Q4 		$230K Sell
7,880
-1,676
-18% -$53.3K 0.01% 899
2022
Q3 		$252K Sell
9,556
-2,505
-21% -$91.9K 0.01% 917
2022
Q2 		$536K Buy
12,061
+20
+0.2% +$919 0.02% 674
2022
Q1 		$596K Sell
12,041
-1,781
-13% -$85.5K 0.01% 720
2021
Q4 		$704K Buy
13,822
+71
+0.5% +$3.68K 0.01% 741
2021
Q3 		$767K Sell
13,751
-590
-4% -$29K 0.02% 640
2021
Q2 		$614K Buy
14,341
+4,116
+40% +$170K 0.01% 820
2021
Q1 		$427K Buy
10,225
+5,032
+97% +$234K 0.01% 920
2020
Q4 		$242K Hold
5,193
– – 0.01% 1071
2020
Q3 		$221K Hold
5,193
– – 0.01% 1017
2020
Q2 		$249K Sell
5,193
-80
-2% -$3.99K 0.01% 960
2020
Q1 		$243K Sell
5,273
-82
-2% -$4.12K 0.01% 948
2019
Q4 		$322K Sell
5,355
-136
-2% -$8.11K 0.01% 1041
2019
Q3 		$311K Sell
5,491
-47
-0.8% -$2.64K 0.01% 1057
2019
Q2 		$308K Sell
5,538
-129
-2% -$6.73K 0.01% 1055
2019
Q1 		$286K Hold
5,667
– – 0.01% 1055
2018
Q4 		$228K Sell
5,667
-500
-8% -$25.8K 0.01% 1025
2018
Q3 		$428K Hold
6,167
– – 0.01% 1001
2018
Q2 		$467K Sell
6,167
-283
-4% -$17.8K 0.01% 954
2018
Q1 		$340K Hold
6,450
– – 0.01% 992
2017
Q4 		$345K Sell
6,450
-4,077
-39% -$227K 0.01% 985
2017
Q3 		$628K Buy
+10,527
New +$637K 0.01% 773

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Shell Asset Management's EGRX Position: Q3 2023 in Review

Shell Asset Management sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2023, closing a stake of 7,809 shares — an estimated $152K sold.

Shell Asset Management first reported a position in EGRX in Q3 2017 and held it in 24 quarters. The position peaked at $767K in Q3 2021. 107 funds tracked by Wall St. Rank hold EGRX as of Q3 2023.

  • Shell Asset Management reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Shell Asset Management sold 7,809 Eagle Pharmaceuticals, Inc. shares in Q3 2023, an estimated $152K.
  • Shell Asset Management first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2017 and held it in 24 quarters.
  • Shell Asset Management's Eagle Pharmaceuticals, Inc. position peaked at $767K in Q3 2021.
  • 107 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2023.

Based on Shell Asset Management's 13F filing for Q3 2023, filed 8 Nov 2023.